Christopher Accettella Purchases 1,190 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) Portfolio Manager Christopher Accettella acquired 1,190 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Thursday, January 11th. The shares were purchased at an average cost of 15.17 per share, for a total transaction of 18,052.30. Following the purchase, the portfolio manager now directly owns 4,070 shares in the company, valued at 61,741.90. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at 15.89 on Friday. The company’s 50 day simple moving average is 15.86 and its 200 day simple moving average is 15.53. BlackRock Health Sciences Term Trust has a fifty-two week low of 12.93 and a fifty-two week high of 16.59.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be paid a dividend of $0.176 per share. This represents a $2.11 annualized dividend and a yield of 13.29%. The ex-dividend date is Tuesday, October 15th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Oppenheimer & Co. Inc. lifted its stake in BlackRock Health Sciences Term Trust by 2.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock valued at $1,124,000 after buying an additional 1,536 shares in the last quarter. LM Advisors LLC bought a new position in BlackRock Health Sciences Term Trust in the fourth quarter valued at approximately $1,591,000. Virtu Financial LLC lifted its stake in BlackRock Health Sciences Term Trust by 71.2% in the fourth quarter. Virtu Financial LLC now owns 19,857 shares of the company’s stock valued at $291,000 after buying an additional 8,256 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in BlackRock Health Sciences Term Trust by 17.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 30,559 shares of the company’s stock valued at $448,000 after buying an additional 4,604 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC lifted its stake in BlackRock Health Sciences Term Trust by 9.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock valued at $360,000 after buying an additional 1,845 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.